1 |
Stevens MJ, Feldman EL, Greene DA. The etiology of diabetic neuropathy: The combined roles of metabolic and vascular defect. Diabetic Med 1995; 12(7): 1566-1579
DOI
ScienceOn
|
2 |
McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56(1): 111-128
PUBMED
ScienceOn
|
3 |
Paolisso G, D'Amore A, Giugliano D, Cereillo A, Varricchio M, D'Onofrio F. Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients. Am J Clin Nutr 1993; 57(5): 650-656
DOI
PUBMED
|
4 |
Davie SJ, Gould BJ, Yudkin JS. Effect of Vitamin C on glycosylation of protein. Diabetes 1992; 41(2): 167-173
DOI
ScienceOn
|
5 |
Varillo AR, Ade T, Golia R, Nunziata V. The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance. Diabetologia 1983; 24(5): 391-393
DOI
PUBMED
|
6 |
Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000; 23(12): 1816-1822
DOI
ScienceOn
|
7 |
Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998; 18(1): 133-138
DOI
PUBMED
|
8 |
Rinkins LE. Effects of alloxan diabetes on rat river ascorbic acid. Horm Metab Res 1981; 13(2): 123-129
DOI
PUBMED
|
9 |
Sies H, Stahl W. Vitamin E and vitamin C and carotenoid as antioxidants. Am J Clin Nutr 1995; 62(6): 1315s-1321s
DOI
PUBMED
|
10 |
Nappo F, De Rosa N, Marfella F, De Lucia D, Ingrosso D, Perna AF, Fazati B, Giugliano D. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999; 281(22): 2113-2118
DOI
ScienceOn
|
11 |
Park HS, Lee YM. Effects of vitamin C supplementation on blood sugar and antioxidative status in type 2 diabetes mellitus patients. J Korean Acad Nurs 2003; 33(2): 170-178
DOI
|
12 |
Fonseca VA, Stone A, Munshi M, Baliga BS, Aljada A, Thusu K, Fink L, Candona P. Oxidative stress in diabetic macrovascular disease: does homocysteine play a role? South Med J 1997; 90(9): 903-906
DOI
PUBMED
|
13 |
Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 2000; 43(2): 148-155
DOI
ScienceOn
|
14 |
Moghadasion MH, McManus BM, Frohlich JJ. Homocysteine and coronary heart disease; clinical evidence and genetic and metabolic background. Arch Intern Med 1997; 157(20): 2299-2308
DOI
ScienceOn
|
15 |
Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvåle G. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995; 274(19): 1526-1533
DOI
ScienceOn
|
16 |
Young IS, Lightbody JH, McMaster D, Trimble ER. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995; 18(5): 833-840
DOI
ScienceOn
|
17 |
Medina MA, Amores-Snchez MI. Homocysteine: an emergent cardiovascular risk factor? Eur J Clin Invest 2000; 30(9): 754-762
DOI
ScienceOn
|
18 |
Hwang MR, Shin MH, Rhee JA, Kweon SS, Lim HS. Effects of folic acid or ascorbate supplemendation on plasma homocysteine levels and oxidative stress in Korean adults with impared fasting glucose. Korean J Community Nutrition 2008; 13(2):263-275
|
19 |
Shukla N, Angelini GD, Jeremy JY. The administration of folic acid reduces intravascular oxidative stress in diabetic rabbits. Metabolism 2008; 57(6): 774-781
DOI
ScienceOn
|
20 |
van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 2000; 26(3): 281-289
DOI
ScienceOn
|
21 |
Ha AW, Kim HM. The study of lipid-peroxidation, antioxidant enzymes, and the antioxidant vitamin in NIDDM patients with microvascular-diabetic complications. Korean J Nutr 1999; 32(1): 17-23
|
22 |
Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regarding to age, gender, and menopausal status. Eur J Clin Invest 1992; 22(2): 74-87
DOI
ScienceOn
|
23 |
Lim HS. Folate status in pregnant and lactating women. J Korean Soc Food Sci Nutr 1997; 26(5): 983-992
|
24 |
Dipolack AT. Safety of antioxidation vitamins and beta-carotene. Am J Clin Nutr 1995; 62(6): 1510s-1516s
DOI
PUBMED
|
25 |
Kim NE, Kim WK. Effects of antioxidant vitamin supplementation on antioxidative status and plasma lipid profiles in Korean NIDDM patients. Korean J Nutr 1999; 32(7): 775-780
|
26 |
Brattstrom L. Vitamins as homocysteine-lowering agents. J Nutr 1996; 126(4): 1276s-1280s
DOI
PUBMED
|
27 |
Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD. Serum Homocysteine levels are associated with the development of microalbuminuria: the Hoorn Study. Arterioscler Thromb Vasc Biol 2001; 21(1): 74-81
DOI
PUBMED
|
28 |
Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993; 103(2): 149-157
DOI
ScienceOn
|
29 |
Aukrus P, Berge RK, Muller F, Ueland PM, Svardal AM, Froland SS. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency-a marker of enhanced oxidative stress. Eur J Clin Invest 1997; 27(10): 723-730
DOI
ScienceOn
|
30 |
McCully KS. Chemical pathology of homocysteine I. Atherogenesis. Ann Clin Lab Sci 1993; 23(6): 477-493
PUBMED
|
31 |
Targher G, Bertolini L, Zenari L, Cacciatori V, Muggeo M, Faccini G, Zppini G. Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care 2000; 23(4): 524-528
DOI
ScienceOn
|
32 |
Chauvear P, Chadefaux B, Coud M, Aupetit J, Kamoun P, Jungers P. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 1996; 22(1-3): 106-109
PUBMED
|
33 |
Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Noble MI. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 2000; 36(4): 1217-1222
DOI
ScienceOn
|
34 |
Song IJ, Lee JA, Lim HS. Dietary and health-related lifestyle habits and blood parameters of non-insulin dependent diabetes patients. Nutr Sci 2005; 8(1): 35-41
과학기술학회마을
|
35 |
Blom HJ, Kleinveld HA, Boers GH, Demacker PN, Hak-Lemmers HL, Te Poele-Pothoff MT, Trijbels JM. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinemia. Eur J Clin Invest 1995; 25(3): 149-154
DOI
ScienceOn
|
36 |
Yoshida H, Ishikawa T, Nakamura H. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in NIDDM. Arterioscler Throm Vasc Biol 1997; 17(7): 1438-1446
DOI
|
37 |
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339(4): 229-234
DOI
ScienceOn
|
38 |
Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67(2): 263-270
DOI
PUBMED
|
39 |
Som S, Basu S, Mukherjee D, Deb S, Choudhury PR, Mukherjee S. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30(6): 572-577
DOI
ScienceOn
|
40 |
Racek J, Rusnkov H, Trefil L, Siala KK. The Influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Res 2005; 54(1): 87-95
PUBMED
|
41 |
Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes 5-year followup of the Hoorn Study. Circulation 2000; 101(13):1506-1511
DOI
PUBMED
|
42 |
Seo HY, Ha AW, Cho JS. The dietary intake, plasma lipid peroxidation and vitamin C in NIDDM patients. Korean J Nutr 2001; 34(8): 912-919
|
43 |
Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R, Vermaak WJ. The effect of a subnormal vitamin B6 status on homocysteine metabolism. J Clin Invest 1996; 98(1):177-184
DOI
ScienceOn
|
44 |
Okamura M. An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. Clin Chem Acta 1980; 103(3): 259-268
DOI
ScienceOn
|
45 |
Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340(19):1449-1454
DOI
ScienceOn
|
46 |
Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999; 99(9): 1156-1160
DOI
PUBMED
|
47 |
Chang NS, Kim JM, Park SW, Cho YW, Kwon OO. Folate intake and plasma homocysteine levels in the elderly patients with NIDDM. Korean J Nutr 2000; 33(3): 250-256
|